1. Home
  2. Proposition 65
  3. Overview of the December 2024 Meeting of the Ca...

Overview of the December 2024 Meeting of the Carcinogen Identification Committee (CIC)

The Carcinogen Identification Committee (CIC) voted in favor of listing vinyl acetate as a carcinogen under Proposition 65 by a vote of 11 (yes) to 0 (no). A recording of the full meeting and transcript will be posted online when available.

A meeting of the CIC was held on December 19, 2024, starting at 10:00 am. During the meeting, OEHHA staff presented a summary of evidence on the carcinogenicity of vinyl acetate. This was followed by a discussion and deliberation on the evidence by the CIC, and by public comment. The CIC then determined that vinyl acetate was clearly shown, through scientifically valid testing according to generally accepted principles, to cause cancer by a vote of 11 (yes) to 0 (no).

Ahead of the meeting, OEHHA had issued a request for relevant information on the potential carcinogenicity of vinyl acetate, which opened on July 7, 2023 and closed on September 18, 2023. The data call-in was followed by publication of the hazard identification document entitled “Evidence on the Carcinogenicity of Vinyl Acetate” and a public comment period from October 4, 2024 to November 18, 2024.

At the meeting, the CIC also voted 11 — 0, in favor of the consent item to add 2,2,3-trifluoro-3-(trifluoromethyl)oxirane (also known as hexafluoropropylene oxide, or HFPO) to the list of chemicals for which testing is required but has been inadequate (California Code of Regulations (CCR) Title 27 Section 27000). As described in the OEHHA staff report, data requirements for HFPO are still required. This list of chemicals is distinct from the Proposition 65 list.

Finally, OEHHA staff presented updates on chemical listing via the administrative listing mechanisms, safe harbor levels, and other regulations and litigation since the last CIC meeting.

OEHHA was pleased  to swear in two new members of the CIC; Dr. Ludmil Alexandrov, Associate Professor in the departments of Bioengineering and Cellular and Molecular Medicine at the University of California San Diego; and Dr. Dean Felsher, Professor of Medicine and Pathology at Stanford University School of Medicine. Both were appointed to the CIC by the Governor in 2024.

Meeting Agenda

  1. Welcome and Opening Remarks
  2. Swearing in of New CIC Members
  3. Consideration of Listing Vinyl Acetate for Carcinogenicity under Proposition 65:
    1. Staff presentation
    2. Committee discussion
    3. Public comments
    4. Committee discussion and decision
  4. Consent Item - Update of the California Code of Regulations Title 27 Section 27000 List of Chemicals Which Have Not Been Adequately Tested as Required
  5. Staff Updates
    1. Chemical listings via the administrative listing mechanisms
    2. Safe harbor levels
    3. Other regulations and litigation
  6. Summary of Committee Actions

Downloads